首页> 外文期刊>Scientific reports. >Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa
【24h】

Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa

机译:利用比较蛋白质组学的潜在疫苗靶标的优先序列,并对嵌合多表位疫苗设计对Pseudomonas铜绿假单胞菌的设计

获取原文
           

摘要

Multidrug-resistant Pseudomonas aeruginosa is one of the worldwide health problems involved inelevated mortality and morbidity. Therefore, it is important to fnd a therapeutic for this pathogen.In the present study, we have designed a chimeric vaccine against P. aeruginosa with the help ofcomparative proteomics and reverse vaccinology approaches. Using comparative subtractive proteomicanalysis of 1,191 proteomes of P. aeruginosa, a total of twenty unique non-redundant proteomeswere selected. In these proteomes, ffteen outer membrane proteins (OMPs) of P. aeruginosa wereselected based on the basis of hydrophilicity, non-secretory nature, low transmembrane helix (1),essentiality, virulence, pathway association, antigenic, and protein-protein network analysis. Reversevaccinology approach was used to identify antigenic and immunogenic MHC class I, MHC class II and Bcell epitopes present in the selected OMPs that can enhance T cell and B cell mediated immunogenicity.The selected epitopes were shortlisted based on their allergenicity, toxicity potentials, solubility, andhydrophilicity analysis. Immunogenic peptides were used to design a multi-epitope vaccine construct.Immune-modulating adjuvants and PADRE (Pan HLA-DR epitopes) sequence were added with epitopessequence to enhance the immunogenicity. All the epitopes, adjuvants and PADRE sequence werejoined by linkers. The designed vaccine constructs (VT1, VT2, VT3, and VT4) were analyzed by theirphysiochemical properties using diferent tools. Selected chimeric vaccine constructs (VT1, VT3, andVT4) were further shortlisted by their docking score with diferent HLA alleles. The fnal selected VT4construct was docked with TLR4/MD2 complex and confrmed by molecular dynamics simulationstudies. The fnal vaccine VT-4 construct was in-silico cloned in pET28a. Therefore, the designedconstruct VT4 may be studied to control the interaction of P. aeruginosa with host and infection causedby P. aeruginosa.
机译:多药抗性假单胞菌铜绿假单胞菌是全球健康问题之一,涉及缺乏死亡率和发病率。因此,对该病原体进行治疗至关重要。本研究中,我们设计了针对P. Aeruginosa的嵌合疫苗,伴随着离心蛋白质组学和反向疫苗学方法。使用P. Aerginosa的1,191蛋白蛋白质组的比较减法蛋白质模块分析,共选择了20个独特的非冗余蛋白质。在这些蛋白质蛋白质中,基于亲水性,非分泌性质,低跨膜螺旋(<1),基本性,毒力,途径,抗原和蛋白质 - 蛋白网络,P.铜绿假单胞菌的FFTEEN外膜蛋白(OMP)。分析。 Reversevconginology方法用于鉴定所选OMP中存在的抗原和免疫原性MHC I类,MHC II类和BCell表位,其可以增强T细胞和B细胞介导的免疫原性。基于其过敏性,毒性电位,溶解性,所选表位术语入围。和水分性分析。免疫原性肽用于设计多表位疫苗构建体。将免疫调节佐剂和PADRE(PAN HLA-DR表位)序列加入齿性大肠杆菌以增强免疫原性。所有表位,佐剂和PADRE序列都被接头均。通过使用不同的工具对设计的疫苗构建体(VT1,VT2,VT3和VT4)分析。选择的嵌合疫苗构建体(VT1,VT3,ANDVT4)通过与不同的HLA等位基因的对接得分进一步入围。 FNAL选定的VT4Construct与TLR4 / MD2复合物停靠,并由分子动力学模拟仿真组成。 FNAL疫苗VT-4构建体在PET28A中克隆了硅。因此,可以研究设计的编程VT4以控制P.铜绿假单胞菌的铜绿假单胞菌的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号